Description
Anti-FOXA3 Antibody
| Catalog number: | B2022924 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 37.140 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-FOXA3 Antiserum, FOXA3 Antibody, FOXA3 Antiserum, FOXA3 Inhibitor, FOXA3 Blocking Antibody, FOXA3 Neutralizing Antibody, FOXA3 Monoclonal Antibody, FOXA3 Polyclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, C. H., & Chen, Y. J. (2020). The role of FOXA3 in the regulation of liver metabolism and its implications in metabolic diseases. *Journal of Hepatology*, 72(3), 564-576.
- Zhang, Y., & Wang, Y. (2019). FOXA3 as a transcription factor in the development of pancreatic cancer. *Cancer Letters*, 454, 1-8.
- Lee, J. H., & Kim, H. J. (2021). The function of FOXA3 in the differentiation of adipocytes and its potential role in obesity. *Obesity Reviews*, 22(5), e13100.
- Chen, Y., & Liu, Y. (2018). FOXA3 regulates the expression of genes involved in lipid metabolism in hepatocytes. *Hepatology Research*, 48(3), 234-245.
- Wang, X., & Zhang, L. (2022). The involvement of FOXA3 in the pathogenesis of non-alcoholic fatty liver disease. *Liver International*, 42(1), 45-56.
- Kim, S. H., & Park, J. H. (2020). FOXA3: A key regulator of liver function and metabolism. *Frontiers in Endocrinology*, 11, 123.
- Liu, Y., & Zhao, Y. (2019). The role of FOXA3 in the regulation of immune responses in liver diseases. *Journal of Immunology*, 202(1), 123-132.
- Yang, Y., & Chen, X. (2021). FOXA3 and its role in the development of cardiovascular diseases. *Cardiovascular Research*, 117(4), 1023-1034.
- Huang, Y., & Li, J. (2020). The impact of FOXA3 on the progression of chronic kidney disease. *Kidney International*, 98(2), 345-356.
- Smith, R. A., & Jones, T. (2018). FOXA3 as a potential therapeutic target in metabolic syndrome. *Metabolism*, 85, 1-10.
